5.4M
XNAS Volume
High volume today
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 122,733 | - | 0 | Common Stock | |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 272,575 | 272,575 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 272,575 | 272,575 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 106,200 | - | 0 | Common Stock | |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 78,442 | - | 0 | Common Stock | |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 228,225 | 228,225 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 1,300,000 | 1,300,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 272,575 | 272,575 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 131,542 | - | 0 | Common Stock | |
| Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 272,575 | 272,575 | - | - | Stock Option (Right to Buy) | |
| Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 128,777 | - | 0 | Common Stock | |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.92 per share. | 18 Feb 2025 | 6,912 | 77,770 | - | 2.9 | 20,183 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 18 Feb 2025 | 8,345 | 61,237 | - | 2.9 | 24,284 | Common Stock |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.96 per share. | 18 Feb 2025 | 5,521 | 33,479 | - | 3.0 | 16,342 | Common Stock |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 18 Feb 2025 | 6,618 | 86,579 | - | 2.9 | 19,523 | Common Stock |
| Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 18 Feb 2025 | 5,515 | 83,814 | - | 3.0 | 16,380 | Common Stock |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.98 per share. | 13 Feb 2025 | 1,786 | 84,682 | - | 3.0 | 5,322 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 13 Feb 2025 | 1,783 | 69,582 | - | 3.0 | 5,331 | Common Stock |
| Douglas Love | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 13 Feb 2025 | 5,021 | 351,554 | - | 3.0 | 14,812 | Common Stock |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 13 Feb 2025 | 1,425 | 93,197 | - | 3.0 | 4,261 | Common Stock |
| William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 06 Jan 2025 | 37,994 | 356,575 | - | 1.4 | 53,556 | Common Stock |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2025 | 37,994 | 0 | - | - | Stock Option (Right to Buy) | |
| H. William Carson | Director | Purchase of securities on an exchange or from another person at price $ 5.33 per share. | 02 Dec 2024 | 3,200 | 25,600 | - | 5.3 | 17,056 | Common Stock |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 30 Oct 2024 | 78,399 | 274,520 | - | 1.9 | 145,046 | Common Stock |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2024 | 36,050 | 0 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2024 | 78,399 | 0 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 30 Oct 2024 | 36,050 | 310,570 | - | 1.9 | 66,696 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 15 Oct 2024 | 5,408 | 76,773 | - | 1.9 | 10,005 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,408 | 30,646 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 7.41 per share. | 15 Oct 2024 | 5,408 | 71,365 | - | 7.4 | 40,073 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 01 Oct 2024 | 3,200 | 22,400 | - | 6.0 | 19,104 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 19 Sep 2024 | 4,500 | 0 | - | 7.1 | 31,950 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 6.16 per share. | 12 Sep 2024 | 5,500 | 4,500 | - | 6.2 | 33,880 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.64 per share. | 05 Sep 2024 | 5,500 | 10,000 | - | 5.6 | 31,020 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 5.48 per share. | 03 Sep 2024 | 3,200 | 19,200 | - | 5.5 | 17,536 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 29 Aug 2024 | 5,500 | 15,500 | - | 6.0 | 32,725 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 6.24 per share. | 01 Aug 2024 | 3,200 | 16,000 | - | 6.2 | 19,968 | Common Stock |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 15 Jul 2024 | 1,104 | 86,468 | - | 6.0 | 6,657 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 15 Jul 2024 | 1,106 | 71,365 | - | 6.0 | 6,658 | Common Stock |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 15 Jul 2024 | 784 | 94,622 | - | 6.0 | 4,720 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 01 Jul 2024 | 3,200 | 12,800 | - | 5 | 16,000 | Common Stock |
| Thomas G. Wiggans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Muneer A. Satter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Jung E. Choi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 03 Jun 2024 | 3,200 | 9,600 | - | 4.8 | 15,459 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 4.68 per share. | 01 May 2024 | 3,200 | 6,400 | - | 4.7 | 14,982 | Common Stock |
| William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 6.07 per share. | 08 Apr 2024 | 3,200 | 3,200 | - | 6.1 | 19,411 | Common Stock |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 84,651 | - | 0 | Common Stock | |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.51 per share. | 16 Feb 2024 | 2,604 | 72,471 | - | 5.5 | 14,348 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Richard Dean Artis | EVP & CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 89,329 | - | 0 | Common Stock | |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 87,592 | - | 0 | Common Stock | |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 75,075 | - | 0 | Common Stock | |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.53 per share. | 16 Feb 2024 | 2,593 | 82,058 | - | 5.5 | 14,339 | Common Stock |
| Douglas Love | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 656,200 | 656,200 | - | - | Stock Option (Right to Buy) | |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 5.48 per share. | 16 Feb 2024 | 1,951 | 85,641 | - | 5.5 | 10,691 | Common Stock |
| Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 39,000 | - | 0 | Common Stock | |
| Douglas Love | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 12 Feb 2024 | 5,782 | 196,121 | - | 5.5 | 32,032 | Common Stock |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 12 Feb 2024 | 1,810 | 36,075 | - | 5.5 | 10,027 | Common Stock |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 5.53 per share. | 12 Feb 2024 | 1,349 | 48,592 | - | 5.5 | 7,460 | Common Stock |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 12 Feb 2024 | 1,809 | 45,651 | - | 5.5 | 10,022 | Common Stock |
| Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 10,385 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 10,615 | 0 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 27 Dec 2023 | 10,385 | 21,000 | - | 1.9 | 19,213 | Common Stock |
| Ted Yednock | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 27 Dec 2023 | 21,000 | 0 | - | 4.5 | 94,966 | Common Stock |
| Yednock Ted | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 27 Dec 2023 | 10,615 | 10,615 | - | 1.4 | 14,963 | Common Stock |
| Satter A. Muneer | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 26 Dec 2023 | 350,000 | 7,406,024 | - | 2.9 | 1,008,000 | Common Stock |
| Yednock Ted | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 11 Jul 2023 | 21,000 | 37,885 | - | 4.5 | 94,966 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 11 Jul 2023 | 1,057 | 47,460 | - | 3.8 | 4,055 | Common Stock |
| Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 11 Jul 2023 | 10,615 | 48,500 | - | 1.4 | 14,963 | Common Stock |
| Overdorf Michael | EVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 11 Jul 2023 | 978 | 45,802 | - | 3.8 | 3,752 | Common Stock |
| Yednock Ted | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 11 Jul 2023 | 1,057 | 37,885 | - | 3.8 | 4,055 | Common Stock |
| Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 11 Jul 2023 | 10,385 | 58,885 | - | 1.9 | 19,213 | Common Stock |
| Thomas G. Wiggans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Muneer A. Satter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Jung E. Choi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 18,975 | 48,517 | - | 0 | Common Stock | |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,050 | 77,050 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 345,000 | 345,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 18,975 | 46,780 | - | 0 | Common Stock | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,050 | 77,050 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.87 per share. | 15 Feb 2023 | 6,571 | 197,646 | - | 5.9 | 38,564 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 13 Feb 2023 | 166 | 29,542 | - | 6.3 | 1,046 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 13 Feb 2023 | 1,742 | 29,708 | - | 6.3 | 10,989 | Common Stock |
| Michael Overdorf | EVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 13 Feb 2023 | 1,501 | 27,949 | - | 6.3 | 9,461 | Common Stock |
| Michael Overdorf | EVP & Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 13 Feb 2023 | 144 | 27,805 | - | 6.3 | 907 | Common Stock |
| Muneer A. Satter | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 10 Feb 2023 | 2,647,058 | 7,056,024 | - | 6.8 | 17,999,994 | Common Stock |
| Dean Richard Artis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 9,375 | 23,875 | - | 0 | Common Stock | |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,688 | 17,188 | - | 0 | Common Stock | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,688 | 17,188 | - | 0 | Common Stock | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 9,375 | 21,875 | - | 0 | Common Stock | |
| Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 3.84 per share. | 07 Jul 2022 | 2,453,988 | 4,408,966 | - | 3.8 | 9,423,314 | Common Stock |
| Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jul 2022 | 613,497 | 613,497 | - | - | Warrants (Right to Buy) | |
| Thomas G. Wiggins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Muneer A. Satter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Jung E. Choi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 14 Apr 2022 | 60,000 | 200,942 | - | 2.4 | 146,814 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,500 | 14,500 | - | 0 | Common Stock | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,500 | 12,500 | - | 0 | Common Stock | |
| Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 40,000 | 140,942 | - | 0 | Common Stock | |
| Sanjay Keswani | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,500 | 12,500 | - | 0 | Common Stock | |
| Sanjay Keswani | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,500 | 12,500 | - | 0 | Common Stock | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 30,000 | 114,449 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 11 Nov 2021 | 70,942 | 70,942 | - | 1.4 | 100,000 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 11 Nov 2021 | 30,000 | 100,942 | - | 1.9 | 55,503 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 70,942 | 0 | - | - | Stock Option (Right to Buy) | |
| Larry Mattheakis | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 7,500 | 37,994 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 22.05 per share. | 16 Sep 2021 | 7,500 | 0 | - | 22.0 | 165,341 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 16 Sep 2021 | 7,500 | 7,500 | - | 1.4 | 10,572 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.49 per share. | 13 Sep 2021 | 3,500 | 5,500 | - | 7.5 | 26,210 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 3,500 | 143,793 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 13 Sep 2021 | 3,500 | 2,000 | - | 20.0 | 70,034 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 13 Sep 2021 | 16,190 | 0 | - | 20.0 | 323,860 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 13 Sep 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.11 per share. | 13 Sep 2021 | 1,190 | 16,190 | - | 5.1 | 6,081 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,190 | 67,939 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 15,000 | 10,615 | - | - | Stock Option (Right to Buy) | |
| William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 22.31 per share. | 07 Jun 2021 | 3,750 | 0 | - | 22.3 | 83,667 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 3,750 | 45,494 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 3,750 | 49,244 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 07 Jun 2021 | 3,750 | 0 | - | 22.6 | 84,563 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 07 Jun 2021 | 3,750 | 3,750 | - | 1.4 | 5,286 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 07 Jun 2021 | 3,750 | 3,750 | - | 1.4 | 5,286 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 03 Jun 2021 | 12,816 | 2,184 | - | 21.4 | 274,884 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 25,615 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.72 per share. | 03 Jun 2021 | 2,184 | 0 | - | 21.7 | 47,441 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Thomas G. Wiggins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Muneer A. Satter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Jung E. Choi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Ricky L. Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 3,500 | 147,293 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.24 per share. | 27 May 2021 | 3,500 | 2,000 | - | 22.2 | 77,835 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.49 per share. | 27 May 2021 | 3,500 | 5,500 | - | 7.5 | 26,210 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 500 | 52,994 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 31 Mar 2021 | 7,102 | 7,102 | - | 1.4 | 10,011 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.11 per share. | 31 Mar 2021 | 7,102 | 0 | - | 28.1 | 199,621 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 31 Mar 2021 | 500 | 500 | - | 1.4 | 705 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.19 per share. | 31 Mar 2021 | 200 | 300 | - | 28.2 | 5,638 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 31 Mar 2021 | 300 | 0 | - | 28.0 | 8,403 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 7,102 | 53,494 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 29 Mar 2021 | 3,750 | 3,750 | - | 1.4 | 5,286 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2021 | 3,750 | 60,596 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2021 | 3,750 | 64,346 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 24.78 per share. | 29 Mar 2021 | 1,850 | 0 | - | 24.8 | 45,851 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 29 Mar 2021 | 1,900 | 1,850 | - | 24.3 | 46,115 | Common Stock |
| Douglas Love | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 29 Mar 2021 | 3,750 | 3,750 | - | 1.4 | 5,286 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 27.24 per share. | 29 Mar 2021 | 300 | 0 | - | 27.2 | 8,171 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 26.42 per share. | 29 Mar 2021 | 600 | 300 | - | 26.4 | 15,851 | Common Stock |
| Douglas Love | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 29 Mar 2021 | 2,850 | 900 | - | 25.0 | 71,312 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.11 per share. | 25 Mar 2021 | 1,175 | 16,175 | - | 5.1 | 6,004 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 1,175 | 69,129 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 15,000 | 40,615 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 25 Mar 2021 | 237 | 0 | - | 30.0 | 7,101 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.21 per share. | 25 Mar 2021 | 5,680 | 237 | - | 29.2 | 165,914 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 25 Mar 2021 | 10,258 | 5,917 | - | 28.5 | 292,755 | Common Stock |
| Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 25 Mar 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Sanjay Keswani | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 24 Mar 2021 | 3,995 | 0 | - | 30.2 | 120,512 | Common Stock |
| Sanjay Keswani | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 3,995 | 182,956 | - | - | Stock Option (Right to Buy) | |
| Sanjay Keswani | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.49 per share. | 24 Mar 2021 | 3,995 | 3,995 | - | 7.5 | 29,917 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 23 Mar 2021 | 1,400 | 5,600 | - | 27.5 | 38,509 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 5,000 | 150,793 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.16 per share. | 23 Mar 2021 | 1,800 | 2,000 | - | 29.2 | 52,493 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.43 per share. | 23 Mar 2021 | 1,800 | 3,800 | - | 28.4 | 51,175 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.49 per share. | 23 Mar 2021 | 5,000 | 7,000 | - | 7.5 | 37,443 | Common Stock |
| Jennifer Lew | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Ted Yednock | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Douglas Love | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| Sanjay Keswani | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| William H. Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Lew | EVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Jul 2020 | 2,000 | 2,000 | - | 17 | 34,000 | Common Stock |
| Muneer A. Satter | None | 28 Jul 2020 | 2,812,543 | 0 | - | - | Series D Preferred Stock | ||
| Muneer A. Satter | None | 28 Jul 2020 | 1,754,978 | 1,754,978 | - | - | Common Stock | ||
| Muneer A. Satter | None | 28 Jul 2020 | 4,016,573 | 0 | - | - | Series B Preferred Stock | ||
| Muneer A. Satter | None | 28 Jul 2020 | 3,095,238 | 0 | - | - | Series A-1 Preferred Stock | ||
| Muneer A. Satter | None | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Jul 2020 | 200,000 | 1,954,978 | - | 17 | 3,400,000 | Common Stock |
| Muneer A. Satter | None | 28 Jul 2020 | 5,537,036 | 0 | - | - | Series C Preferred Stock | ||
| Michael Overdorf | EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 242,905 | 242,905 | - | - | Stock Option (Right to Buy) |